Common use of Patent Listing Clause in Contracts

Patent Listing. Following Vertex’s exercise of the Option for a Collaboration Target, Vertex will have the sole right, but not the obligation, to submit to all applicable Regulatory Authorities patent information pertaining to each applicable Product pursuant to 21 U.S.C. § 355(b)(1)(G) (or any amendment or successor statute thereto), any similar statutory or regulatory requirement enacted in the future regarding biologic products, or any similar statutory or regulatory requirement in any non-U.S. country or other regulatory jurisdiction; provided that Vertex shall not be permitted to provide any such information with respect to CRISPR Platform Technology Patents without CRISPR’s prior written consent.

Appears in 4 contracts

Samples: Option and License Agreement, Collaboration, Option and License Agreement (CRISPR Therapeutics AG), Collaboration, Option and License Agreement (CRISPR Therapeutics AG)

AutoNDA by SimpleDocs

Patent Listing. Following Vertex’s exercise of the Option for a Collaboration Target, Vertex will have the sole right, but not the obligation, to submit to all applicable Regulatory Authorities patent information pertaining to each applicable Product pursuant to 21 U.S.C. § 355(b)(1)(G) (or any amendment or successor statute thereto), any similar statutory or regulatory requirement enacted in the future regarding biologic products, or any similar statutory or regulatory requirement in any non-U.S. country or other regulatory jurisdiction; provided that Vertex shall not be permitted to provide any such information with respect to CRISPR Platform Technology Licensed Patents without CRISPR’s prior written consent.

Appears in 1 contract

Samples: Non Exclusive License Agreement (CRISPR Therapeutics AG)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.